New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
www.shawlocal.com
U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
  • Another Person @lemmy.worldEnglish
    1·
    1 year ago

    It seems this is not a vaccine but instead injectable antibodies. I’d be curious the longevity of such a therapy as well as what the risks are of those antibodies being triggered by a different disease or how it would affect those with an autoimmune disease.